34 related articles for article (PubMed ID: 9430315)
1. Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review.
Baudou E; Nemmi F; Biotteau M; Maziero S; Peran P; Chaix Y
Front Neurol; 2019; 10():1373. PubMed ID: 31993017
[TBL] [Abstract][Full Text] [Related]
2. Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.
Schütze M; de Souza Costa D; de Paula JJ; Malloy-Diniz LF; Malamut C; Mamede M; Miranda DM; Brammer M; Romano-Silva MA
PLoS One; 2018; 13(9):e0203520. PubMed ID: 30192842
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA).
Stivaros S; Garg S; Tziraki M; Cai Y; Thomas O; Mellor J; Morris AA; Jim C; Szumanska-Ryt K; Parkes LM; Haroon HA; Montaldi D; Webb N; Keane J; Castellanos FX; Silva AJ; Huson S; Williams S; Gareth Evans D; Emsley R; Green J;
Mol Autism; 2018; 9():12. PubMed ID: 29484149
[TBL] [Abstract][Full Text] [Related]
4. GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
Violante IR; Patricio M; Bernardino I; Rebola J; Abrunhosa AJ; Ferreira N; Castelo-Branco M
Neurology; 2016 Aug; 87(9):897-904. PubMed ID: 27473134
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle and motor deficits in Neurofibromatosis Type 1.
Summers MA; Quinlan KG; Payne JM; Little DG; North KN; Schindeler A
J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):161-70. PubMed ID: 26032208
[TBL] [Abstract][Full Text] [Related]
6. Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.
Apostolova I; Niedzielska D; Derlin T; Koziolek EJ; Amthauer H; Salmen B; Pahnke J; Brenner W; Mautner VF; Buchert R
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1304-12. PubMed ID: 25785829
[TBL] [Abstract][Full Text] [Related]
7. Reduced cerebral arterial spin-labeled perfusion in children with neurofibromatosis type 1.
Yeom KW; Lober RM; Barnes PD; Campen CJ
AJNR Am J Neuroradiol; 2013 Sep; 34(9):1823-8. PubMed ID: 23764727
[TBL] [Abstract][Full Text] [Related]
8. Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.
Violante IR; Ribeiro MJ; Silva ED; Castelo-Branco M
J Neurodev Disord; 2013 Feb; 5(1):3. PubMed ID: 23406822
[TBL] [Abstract][Full Text] [Related]
9. Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1.
Duarte JV; Ribeiro MJ; Violante IR; Cunha G; Silva E; Castelo-Branco M
Hum Brain Mapp; 2014 Jan; 35(1):89-106. PubMed ID: 22965669
[TBL] [Abstract][Full Text] [Related]
10. Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.
Moharir M; London K; Howman-Giles R; North K
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1309-17. PubMed ID: 20179923
[TBL] [Abstract][Full Text] [Related]
11. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
[TBL] [Abstract][Full Text] [Related]
12. Has PET become an important clinical tool in paediatric imaging?
Hahn K; Pfluger T
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):615-21. PubMed ID: 14762700
[No Abstract] [Full Text] [Related]
13. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.
Steen RG; Taylor JS; Langston JW; Glass JO; Brewer VR; Reddick WE; Mages R; Pivnick EK
AJNR Am J Neuroradiol; 2001 May; 22(5):810-7. PubMed ID: 11337320
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography in children with neurofibromatosis-1.
Kaplan AM; Chen K; Lawson MA; Wodrich DL; Bonstelle CT; Reiman EM
J Child Neurol; 1997 Nov; 12(8):499-506. PubMed ID: 9430315
[TBL] [Abstract][Full Text] [Related]
15. Metabolic changes of subcortical structures in intractable focal epilepsy.
Benedek K; Juhász C; Muzik O; Chugani DC; Chugani HT
Epilepsia; 2004 Sep; 45(9):1100-5. PubMed ID: 15329075
[TBL] [Abstract][Full Text] [Related]
16. Cerebral glucose metabolism in adults with neurofibromatosis type 1.
Apostolova I; Derlin T; Salamon J; Amthauer H; Granström S; Brenner W; Mautner VF; Buchert R
Brain Res; 2015 Nov; 1625():97-101. PubMed ID: 26335059
[TBL] [Abstract][Full Text] [Related]
17. Statistical image analysis of cerebral glucose metabolism in patients with cognitive impairment following diffuse traumatic brain injury.
Kato T; Nakayama N; Yasokawa Y; Okumura A; Shinoda J; Iwama T
J Neurotrauma; 2007 Jun; 24(6):919-26. PubMed ID: 17600509
[TBL] [Abstract][Full Text] [Related]
18. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
Hamaguchi T; Kitamoto T; Sato T; Mizusawa H; Nakamura Y; Noguchi M; Furukawa Y; Ishida C; Kuji I; Mitani K; Murayama S; Kohriyama T; Katayama S; Yamashita M; Yamamoto T; Udaka F; Kawakami A; Ihara Y; Nishinaka T; Kuroda S; Suzuki N; Shiga Y; Arai H; Maruyama M; Yamada M
Neurology; 2005 Feb; 64(4):643-8. PubMed ID: 15728285
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
